ASCO 2024 - Global Speaker Series - Dr. Erika P. Hamilton presents the compelling results from the Phase I trial of H3B-6545

Dr. Erika P. Hamilton delves into the evidence and insights from the trial, highlighting the potential impact on breast cancer treatment.